BioCentury
ARTICLE | Finance

Europe’s piece of the pie

Where European life science innovators can take the lead

May 17, 2018 7:34 PM UTC

With China’s rising infrastructure for life science innovation and the unabated growth of U.S. science, Europe has two cards to play that can help it compete globally: expertise in key core technologies and its centralized clearinghouses to support translation and access early stage investors.

The core strengths, which include cell and gene therapies, biomarker discovery, rare diseases and neurodegeneration, could position Europe as a driving force as precision medicine and genomics become central to biomedical innovation...